Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$1.86 USD
-0.01 (-0.53%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $1.87 +0.01 (0.54%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO11/13/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 7.14% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -2.24 |
EPS (TTM) | -1.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.21 | -0.98 | -2.24 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.23 | -0.21 | -0.98 | -2.24 |
High Estimate | -0.23 | -0.21 | -0.98 | -2.24 |
Low Estimate | -0.23 | -0.21 | -0.98 | -2.24 |
Year ago EPS | -0.24 | -0.38 | -1.15 | -0.98 |
Year over Year Growth Est. | 4.17% | 44.74% | 14.78% | -128.57% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.21 | -0.98 | -2.24 |
7 Days Ago | -0.23 | -0.21 | -0.98 | -2.24 |
30 Days Ago | -0.23 | -0.21 | -0.98 | -2.24 |
60 Days Ago | -0.23 | -0.21 | -0.98 | -2.24 |
90 Days Ago | -0.26 | -0.45 | -1.28 | -2.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.21 | -0.98 | -2.24 |
Zacks Consensus Estimate | -0.23 | -0.21 | -0.98 | -2.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.28 | -0.38 | -0.24 | NA |
Estimate | -0.28 | -0.24 | -0.26 | -0.28 | NA |
Difference | 0.02 | -0.04 | -0.12 | 0.04 | -0.03 |
Surprise | 7.14% | -16.67% | -46.15% | 14.29% | -10.35% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more